Retrospective study for efficacy of venetoclax in patients with relapsed T-Cell Prolymphocytic Leukemia
Latest Information Update: 11 Jan 2021
At a glance
- Drugs Venetoclax (Primary) ; Bendamustine
- Indications T-cell prolymphocytic leukaemia
- Focus Adverse reactions; Therapeutic Use
- 11 Jan 2021 New trial record
- 08 Dec 2020 Results presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology